FTI insider plans sale of 80,304 shares via Morgan Stanley ($3.08M)
Rhea-AI Filing Summary
The filing is a Form 144 notice from an insider related to TechnipFMC plc (symbol FTI) proposing the sale of 80,304 common shares via Morgan Stanley Smith Barney on the NYSE, with an aggregate market value of $3,079,481.73. The filer reports the shares were acquired in open-market purchases on 12/31/2018 (50,000 shares) and 01/17/2017 (30,304 shares) and paid for in cash. The filing states no securities were sold by the person in the past three months and includes the standard representation that the signer is unaware of undisclosed material adverse information.
Positive
- None.
Negative
- None.
Insights
TL;DR: Proposed sale is small relative to total shares outstanding and appears routine open-market disposition.
The filing notifies the market of an intended sale of 80,304 common shares valued at $3.08 million. Compared with 411,016,473 shares outstanding, this represents a de minimis percentage of the float and is unlikely to be materially value-driving for shareholders. The shares were acquired in prior open-market purchases and paid in cash, which reduces concerns about pledged or derivative-related forced sales. No sales in the past three months were reported, suggesting this is a singular planned disposition rather than a pattern disclosed here.
TL;DR: Form 144 is a compliance filing; it signals disclosure of insider selling but contains no governance red flags.
The document provides required compliance disclosure under Rule 144 for an insider sale executed through a broker. The representation regarding lack of undisclosed material adverse information and the absence of recent sales are standard. There is no indication of an accelerated program or trading plan cited on this form, and the acquisition history shows normal open-market purchases, not transfers or gifts, which mitigates potential governance concerns tied to off-market transfers or related-party transactions.
FAQ
What does the Form 144 for TechnipFMC (FTI) disclose?
When and how were the shares being sold acquired?
How large is the proposed sale relative to shares outstanding?
Were any securities sold by this person in the past three months?
Which broker and exchange are involved in the proposed sale?